|
1.
|
Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults: Executive Summary of
The Third Report of The National Cholesterol Education Program
(NCEP) Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA.
285:2486–2497. 2001. View Article : Google Scholar
|
|
2.
|
Lim HS, Lip GY and Blann AD: Plasma von
Willebrand factor and the development of the metabolic syndrome in
patients with hypertension. J Clin Endocrinol Metab. 89:5377–5381.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Blann AD, Naqvi T, Waite M and McCollum
CN: von Willebrand factor and endothelial damage in essential
hypertension. J Hum Hypertens. 7:107–111. 1993.PubMed/NCBI
|
|
4.
|
Felmeden DC, Spencer CG, Belgore FM, Blann
AD, Beevers DG and Lip GY: Endothelial damage and angiogenesis in
hypertensive patients: relationship to cardiovascular risk factors
and risk factor management. Am J Hypertens. 16:11–20. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Thompson SG, Kienast J, Pyke SD, Haverkate
F and van de Loo C; European Concerted Action on Thrombosis and
Disabilities Angina Pectoris Study Group: Hemostatic factors and
the risk of myocardial infarction or sudden death in patients with
angina pectoris. N Engl J Med. 332:635–641. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Meigs JB, Mittleman MA, Nathan DM, et al:
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the
Framingham Offspring Study. JAMA. 283:221–228. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Alessi MC and Juhan-Vague I: PAI-1 and the
metabolic syndrome: links, causes, and consequences. Arterioscler
Thromb Vasc Biol. 26:2200–2207. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Pi-Sunyer FX: Obesity: criteria and
classification. Proc Nutr Soc. 59:505–509. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Zimmet P, Alberti G, Kaufman F, et al: The
metabolic syndrome in children and adolescents. Lancet.
369:2059–2061. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Alberti KG and Zimmet PZ: Definition,
diagnosis and classification of diabetes mellitus and its
complications. Part 1: diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabet Med.
15:539–553. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Cook S, Weitzman M, Auinger P, Nguyen M
and Dietz WH: Prevalence of a metabolic syndrome phenotype in
adolescents: findings from the third National Health and Nutrition
Examination Survey, 1988–1994. Arch Pediatr Adolesc Med.
157:821–827. 2003.PubMed/NCBI
|
|
12.
|
Steinberger J and Daniels SR: Obesity,
insulin resistance, diabetes, and cardiovascular risk in children:
an American Heart Association scientific statement from the
Atherosclerosis, Hypertension, and Obesity in the Young Committee
(Council on Cardiovascular Disease in the Young) and the Diabetes
Committee (Council on Nutrition, Physical Activity, and
Metabolism). Circulation. 107:1448–1453. 2003.
|
|
13.
|
Hanson M and Gluckman P: Endothelial
dysfunction and cardiovascular disease: the role of predictive
adaptive responses. Heart. 91:864–866. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Versari D, Daghini E, Virdis A, Ghiadoni L
and Taddei S: Endothelial dysfunction as a target for prevention of
cardiovascular disease. Diabetes Care. 32(Suppl 2): S314–S321.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Bell DM, Johns TE and Lopez LM:
Endothelial dysfunction: implications for therapy of cardiovascular
diseases. Ann Pharmacother. 32:459–470. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Dusheiko GM: Review article: the
management of hepatitis A, B, D and non-A non-B. Aliment Pharmacol
Ther. 3:1–20. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Binder BR, Christ G, Gruber F, et al:
Plasminogen activator inhibitor 1: physiological and
pathophysiological roles. News Physiol Sci. 17:56–61.
2002.PubMed/NCBI
|
|
18.
|
Huang K, Zou CC, Yang XZ, et al: Carotid
intima-media thickness and serum endothelial marker levels in obese
children with metabolic syndrome. Arch Pediatr Adolesc Med.
164:846–851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Carr DB, Utzschneider KM, Hull RL, et al:
Intra-abdominal fat is a major determinant of the National
Cholesterol Education Program Adult Treatment Panel III criteria
for the metabolic syndrome. Diabetes. 53:2087–2094. 2004.
View Article : Google Scholar
|
|
20.
|
Aggoun Y: Obesity, metabolic syndrome, and
cardiovascular disease. Pediatr Res. 61:653–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Nesto RW: The relation of insulin
resistance syndromes to risk of cardiovascular disease. Rev
Cardiovasc Med. 4(Suppl 6): S11–S18. 2003.PubMed/NCBI
|
|
22.
|
Chong AY, Blann AD and Lip GY: Assessment
of endothelial damage and dysfunction: observations in relation to
heart failure. QJM. 96:253–267. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Pinkney JH, Stehouwer CD, Coppack SW and
Yudkin JS: Endothelial dysfunction: cause of the insulin resistance
syndrome. Diabetes. 46(Suppl 2): S9–S13. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Conlan MG, Folsom AR, Finch A, et al:
Associations of factor VIII and von Willebrand factor with age,
race, sex, and risk factors for atherosclerosis. The
Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost.
70:380–385. 1993.PubMed/NCBI
|
|
25.
|
Wen Y, Gu J, Li SL, et al: Elevated
glucose and diabetes promote interleukin-12 cytokine gene
expression in mouse macrophages. Endocrinology. 147:2518–2525.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Myers JE and Baker PN: Hypertensive
diseases and eclampsia. Curr Opin Obstet Gynecol. 14:119–125. 2002.
View Article : Google Scholar : PubMed/NCBI
|
